Measles vaccination: Comparing two cohorts with different immunization schedules

Saudi Pharmaceutical Journal

Volumn 12, Issue 4, 2004, Pages 163-167

  Khalil, Mohamed ^a   Al Mazrou, Yagob ^b   Tischer, Annedore ^c   Al Jeffri, Mohamed ^d   Tumsah, Salah ^d   Mishkhas, Ameen ^d   Eissa, Mostafa ^e  

^a King Fahd Specialist Hospital Buraidah   (Saudi Arabia)

^b MMR Reference Lab ^*

^c MOH   (Germany)

^d MINISTRY OF HEALTH   (Saudi Arabia)

^e NONE   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES ANTIBODY; MEASLES MUMPS RUBELLA VACCINE;

ANTIBODY TITER; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FOLLOW UP; HUMAN; IMMUNE STATUS; IMMUNIZATION; MAJOR CLINICAL STUDY; MEASLES; MEASLES VACCINATION; SAUDI ARABIA; SEROCONVERSION;

EID: 11144255667     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Abanamy A, Khalil M, Salman H, Abdulazeem M. Measles vaccine failure. Annals of Saudi Medicine. 1991 ;11:311-314.
2. Abanamy A, Khalil M, Salman H, Abdulazeem M. Follow-up study for measles maternal antibodies and seroconversion after measles vaccination. Annals of Saudi Medicine. 1991; 11:51-53.
3. 10 of Edmonston-Zagreb measles vaccine in solving the problem of measles vaccine failure. Annual Scientific meeting of Egyptian Medical Syndicate(EMS). Cairo. 2-4 February 1993. No. 3
4. 10 Edmonston-Zagreb measles vaccine. Saudi Medical Journal. 1993; 14(1): 44-45
5. Matter L, Germann D, Bally F, Schopfer K. Age-stratified seroprevalence of measles, mumps and rubella (MMR) virus infections in Switzerland after the introduction of MMR mass vaccination. Eur J Epidemiol 1997; 13(1):61-6.
6. Al-Mazrou YY, Al-Jeffri M, Ahmed OM, Aziz MS, Mishkhas AH. Measles immunization: Early two-doses experience. Journal of tropical Pediatrics. 1999; 45:98-104
7. Mansour O, Blakely T, Bajer M, Bloomfield A. A measles epidemic controlled by immunization. N Z Med J 1998; 111(1079):467-71.
8. Muller CP. Measles elimination: old and new challenge. Vaccine. 2001; 19(17-19):2258-2261
9. Khalil M, Poltera AA, Al-Hovvasi M, Herzog C, Gerik E, Wegmuller B, Gluck R. Response to measles revaccination among toddlers in Saudi Arabia by the use of two different trivalent measles-mumps-rubella vaccine. Transaction of the Royal Society of Tropical Medicine and Hygiene. 1999; 214-219.
10. th grade students of 8 different sites in Switzerland in 1995/96. Schweiz Runsch Med Prax 1999 Jun 10;88(24):1069-77.
11. Garly ML, Bale C, Martins CL, Monterio M, George E, Kidd M. et al. Measles antibody responses after early two dose trials in Guinea-Bissau with Edmonston-Zagreb and Schwartz standard-titre measles vaccine: better antibody increase from booster dose of the Edomnston-Zagreb vaccine. Vaccine 2001;19(15-16):1951-1959.
12. Ceyhan M, Kanra G, Erden G, Kanra B. Immunogenicity and efficacy of one dose measles-mumps-rubella (MMR) vaccinae at twelve months of age as compared to monovalent measles vaccination at nine months folloed by MMR revaccination at fifteen months of age. Vaccine 2001 Aug 14;19(31):4473-8
13. Brandenberg AH, Groen J, Van Steensel-Moll HA et al. Respiratory syncytial virus specific serum antibodies in infants under six months of age: limited serological response upon infection. J Med Virol 1997; 52(1):97-104.
14. Johnson CE, Nalin DR, Chui LW, Whittle J, Marusyk RG, Kumar ML. Measles vaccine immunogenicity in 6 versus 15 months old infants born to mothers in the measles vaccine era. Pediatrics. 1994;93(part 1):939-44
15. Paunio M, Hedman K, Davidkin I, et al. Secondary measles vaccines failures identified by measurements of IgG avidity: high occurrence among teenagers vaccinated at a young age. Epidemiol Infect 2000;124(2):263-71.